Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Treasury Shares (2021 - 2025)

Rapid Micro Biosystems' Treasury Shares history spans 5 years, with the latest figure at $2.8 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 44.0% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 million, a 44.0% increase, with the full-year FY2025 number at $2.8 million, up 44.0% from a year prior.
  • Treasury Shares hit $2.8 million in Q4 2025 for Rapid Micro Biosystems, down from $3.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for RPID hit a ceiling of $3.2 million in Q2 2025 and a floor of $248903.0 in Q2 2021.
  • Historically, Treasury Shares has averaged $1.5 million across 5 years, with a median of $1.8 million in 2023.
  • Biggest five-year swings in Treasury Shares: surged 241.75% in 2023 and later rose 15.46% in 2024.
  • Tracing RPID's Treasury Shares over 5 years: stood at $248903.0 in 2021, then surged by 113.79% to $532121.0 in 2022, then surged by 216.05% to $1.7 million in 2023, then grew by 15.46% to $1.9 million in 2024, then skyrocketed by 44.0% to $2.8 million in 2025.
  • Business Quant data shows Treasury Shares for RPID at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $3.2 million in Q2 2025.